Genetic association of the APP binding protein 2 gene (APBB2) with late onset Alzheimer disease

Human Mutation

Volumn 25, Issue 3, 2005, Pages 270-277

  Li, Yonghong ^a   Hollingworth, Paul ^b   Moore, Pamela ^b   Foy, Catherine ^c   Archer, Nicola ^c   Powell, John ^c   Nowotny, Petra ^d   Holmans, Peter ^b   O'Donovan, Michael ^b   Tacey, Kristina ^a   Doil, Lisa ^a   Van Luchene, Ryan ^a   Garcia, Veronica ^a   Rowland, Charles ^a   Lau, Kit ^a   Cantanese, Joseph ^a   Sninsky, John ^a   Hardy, John ^e   Thal, Leon ^f   Morris, John C ^d   Goate, Alison ^d   Lovestone, Simon ^c   Owen, Michael ^b   Williams, Julie ^b   Grupe, Andrew ^a   more..

^a CELERA   (United States)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NATIONAL INSTITUTE ON AGING   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

AD; Alzheimer disease; APBB2; APP; Association; LOAD; SNP

Indexed keywords

AMYLOID PRECURSOR PROTEIN; BINDING PROTEIN;

ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENOME; GENOTYPE; HUMAN; KRUSKAL WALLIS TEST; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; ONSET AGE; PRIORITY JOURNAL; PROTEIN BINDING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AGE OF ONSET; AGED; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTRONS; MALE; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; UNITED STATES; WALES;

EID: 20144365768     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/humu.20138     Document Type: Article

References (29)

1. Athan ES, Lee JH, Arriaga A, Mayeux RP, Tycko B. 2002. Polymorphisms in the promoter of the human APP gene: functional evaluation and allele frequencies in Alzheimer disease. Arch Neurol 59:1793-1799.
2. Bertram L, Blacker D, Crystal A, Mullin K, Keeney D, Jones J, Basu S, Yhu S, Guenette S, McInnis M, Go R, Tanzir R. 2000. Candidate genes showing no evidence for association or linkage with Alzheimer's disease using family-based methodologies. Exp Gerontol 35:1353-1361.
3. Cao H, Pratt N, Mattison J, Zhao Y, Chang NS. 2000. Characterization of an apoptosis inhibitory domain at the C-termini of FE65-like protein. Biochem Biophys Res Commun 276:843-850.
4. Chang Y, Tesco G, Jeong WJ, Lindsley L, Eckman EA, Eckman CB, Tanzi RE, Guenette SY. 2003. Generation of the beta-amyloid peptide and the amyloid precursor protein C-terminal fragment gamma are potentiated by FE65L1. J Biol Chem 278:51100-51107.
5. Cousin E, Mannequin D, Ricard S, Mace S, Genin E, Chansac C, Brice A, Dubois B, Frebourg T, Mercken L, Benavides J, Pradier L, Campion D, Delueze JF. 2003. A risk for early-onset Alzheimer's disease associated with the APBB1 gene (FE65) intron 13 polymorphism. Neurosci Lett 342:5-8.
6. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM. 1997. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278:1349-1356.
7. Germer S, Holland MJ, Higuchi R. 2000. High-throughput SNP allele-frequency determination in pooled DNA samples by kinetic PCR. Genome Res 10:258-266.
8. Glenner GG, Wong CW. 1984. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120:885-890.
9. Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L, Mant R, Newton P, Rooke K, Roques P, Talbot C, Pericak-Vance M, Roses A, Williamson R, Rossor M, Owen M, Hardy J. 1991. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349:704-706.
10. Guenette SY, Chen J, Jondro PD, Tanzi RE. 1996. Association of a novel human FE65-like protein with the cytoplasmic domain of the beta-amyloid precursor protein. Proc Natl Acad Sci USA 93:10832-10837.
11. Guenette SY, Chen J, Ferland A, Haass C, Capell A, Tanzi RE. 1999. hFE65L influences amyloid precursor protein maturation and secretion. J Neurochem 73:985-993.
12. Guenette SY, Bertram L, Crystal A, Bakondi B, Hyman BT, Rebeck GW, Tanzi RE, Blacker D. 2000. Evidence against association of the FE65 gene (APBB1) intron 13 polymorphism in Alzheimer's patients. Neurosci Lett 296:17-20.
13. Hu Q, Kukull WA, Bressler SL, Gray MD, Cam JA, Larson EB, Martin GM, Deeb SS. 1998. The human FE65 gene: genomic structure and an intronic biallelic polymorphism associated with sporadic dementia of the Alzheimer type. Hum Genet 103:295-303.
14. Lambert JC, Mann D, Goumidi L, Harris J, Pasquier F, Frigard B, Cottel D, Lendon C, Iwatsubo T, Amouyel P, Chartier-Harlin MC. 2000. A FE65 polymorphism associated with risk of developing sporadic late-onset Alzheimer's disease but not with Abeta loading in brains. Neurosci Lett 293:29-32.
15. Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pettingell WH, Yu CE, Jondro PD, Schmidt SD, Wang K, Crowley AC, Fu Y-H, Guenette Sy, Galas D, Nemens E, Wijsman EM, Bird TD, Schellenberg GD, Tanzi RE. 1995a. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269:973-977.
16. Levy-Lahad E, Wijsman EM, Nemens E, Anderson L, Goddard KA, Weber JL, Bird TD, Schellenberg GD. 1995b. A familial Alzheimer's disease locus on chromosome 1. Science 269:970-973.
17. Li Y, Nowotny P, Holmans P, Smemo S, Kauwe J, Hinrichs T, Tacey K, Doil L, van Luchene R, Garcia V, Rowland C, Schrodi S, Leong D, Gorgic G, Chan J, Cravchik A, Ross D, Lau K, Kwok S, Chang S.-Y., Catanese J, Sninsky J, White T, Hardy J, Powell J, Lovestone S, Thal L, Owen M, Williams J, Goate A, Grupe A. 2004. Association of late onset Alzheimer's disease with genetic variation in multiple members of the GAPD gene family. Proc Natl Acad Sci USA 101:15688-15693.
18. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. 1984. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34:939-944.
19. Nielsen DM, Ehm MG, Weir BS. 1998. Detecting marker-disease association by testing for Hardy-Weinberg disequilibrium at a marker locus. Am J Hum Genet 63:1531-1540.
20. Olson JM, Goddard KA, Dudek DM. 2001. The amyloid precursor protein locus and very-late-onset Alzheimer disease. Am J Hum Genet 69:895-899.
21. Papassotiropoulos A, Bagli M, Becker K, Jessen F, Maier W, Rao ML, Ludwig M, Heun R. 2000. No association between an intronic biallelic polymorphism of the FE65 gene and Alzheimer's disease. Int J Mol Med 6:587-589.
22. Prince JA, Feuk L, Sawyer SL, Gottfries J, Ricksten A, Nagga K, Bogdanovic N, Blennow K, Brookes AJ. 2001. Lack of replication of association findings in complex disease: an analysis of 15 polymorphisms in prior candidate genes for sporadic Alzheimer's disease. Eur J Hum Genet 9:437-444.
23. Pritchard JK, Stephens M, Donnelly P. 2000. Inference of population structure using multilocus genotype data. Genetics 155:945-959.
24. Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, Liang Y, Chi H, Lin C, Holman K, Tsuda T, Mar L, Sorbi S, Nacmias B. Piacentini S, Amaducci L, Chumakov I, Cohen D, Lennfelt L, Fraser PE, Rommens JM, St. George-Hyslop PH. 1995. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376:775-778.
25. Roses AD. 1998. Apolipoprotein E and Alzheimer's disease. The tip of the susceptibility iceberg. Ann NY Acad Sci 855:738-743.
26. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. 2002. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70:425-434.
27. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K, Tsuda T, Mar L, Foncin J-F, Bruni AC, Montesi MP, Sorbi S, Rainero I, Pinessi L, Nee L, Chumakov I, Pollen D, Brookes A, Sanseau P, Polinsky RJ, Wasco W, Da Silva HAR, Haines JL, Pericak-Vance MA, Tanzi RE, Roses AD, Fraser PE, Rommens JM, St. George-Hyslop PH. 1995. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375:754-760.
28. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD. 1993. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 90:1977-1981.
29. Wavrant-De Vrieze F, Crook R, Holmans P, Kehoe P, Owen MJ, Williams J, Roehl K, Laliiri DK, Shears S, Booth J, Wu W, Goate A, Chartier-Harlin MC, Hardy J, Perez-Tur J. 1999. Genetic variability at the amyloid-beta precursor protein locus may contribute to the risk of late-onset Alzheimer's disease. Neurosci Lett 269:67-70.